Anteris Technologies (AU:AVR) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Anteris Technologies Global Corp., a leader in structural heart innovations, has filed a report with the SEC related to their schemes of arrangement. The company is renowned for its DurAVR® Transcatheter Heart Valve, which mimics a healthy aortic valve to treat aortic stenosis. Their patented ADAPT® tissue technology has been successfully used in over 55,000 patients worldwide.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.
